PHM three-lens brief
Evidence-based stock research on PHM. Three independent lenses — Quality, Momentum, Context — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Underperforming SPY by 8.6pp over 30 days. · Debt-to-equity of 18.9 — balance-sheet-heavy.
- Underperforming SPY by 8.6pp over 30 days.
- P/E of 11.4 — trading at a value multiple.
- Analyst mean target $137.50 — 17% above current (14 analysts).
- Debt-to-equity of 18.9 — balance-sheet-heavy.
PHM closed at $117.60 (-1.35%) as of 2026-05-04. Market cap: $22.40B. P/E (trailing) 11.4. Positives: p/E of 11.4 — trading at a value multiple.; analyst mean target $137.50 — 17% above current (14 analysts).. Concerns: underperforming SPY by 8.6pp over 30 days.; debt-to-equity of 18.9 — balance-sheet-heavy.. Last quarter: Revenue $3.41B, net income $347.00M, free cash flow $1.48B.
Why three lenses on PHM, not one.
A single reasoning model has blind spots it doesn’t know about. We examine PHMacross Quality (fundamentals), Momentum (price action and sentiment), and Context (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/PHM" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath PHM brief"></iframe>